In the preceding three months, 15 analysts have released ratings for Jazz Pharmaceuticals (NASDAQ:JAZZ), presenting a wide array of perspectives from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 6 | 8 | 1 | 0 | 0 |
Last 30D | 1 | 0 | 0 | 0 | 0 |
1M Ago | 0 | 1 | 0 | 0 | 0 |
2M Ago | 4 | 3 | 0 | 0 | 0 |
3M Ago | 1 | 4 | 1 | 0 | 0 |
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $195.73, a high estimate of $230.00, and a low estimate of $131.00. Marking an increase of 1.35%, the current average surpasses the previous average price target of $193.12.
Analyzing Analyst Ratings: A Detailed Breakdown
A clear picture of Jazz...
Login or create a forever free account to read this news
Sign up/Log in